An efficient one-pot three-component synthesis of highly functionalized coumarin fused indenodihydropyridine and chromeno[4,3-b]quinoline derivatives

Article abstract of DOI:10.3987/COM-12-12494

An efficient one-pot, three-component synthesis method of highly functionalized coumarin fused 7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]- phenanthrene and chromeno[4,3-b]quinoline derivatives was accomplished using aromatic aldehyde, 4-aminocoumarin and cyclic 1,3-dione in acetic acid at reflux temperature. Environmental-friendly protocol has advantages of high yields, creating three new bonds and one stereocenter in single operation. Further, XRD and DFT study confirmed the molecular structure, stability and different interaction in the crystal packing.

Full text of DOI:10.3987/COM-12-12494

HETEROCYCLES, Vol. 85, No. 7, 2012
1629
HETEROCYCLES, Vol. 85, No. 7, 2012, pp. 1629 - 1653. © 2012 The Japan Institute of Heterocyclic Chemistry
Received, 19th April, 2012, Accepted, 21st May, 2012, Published online, 24th May, 2012
DOI: 10.3987/COM-12-12494
AN EFFICIENT ONE-POT THREE-COMPONENT SYNTHESIS OF
HIGHLY
FUNCTIONALIZED
COUMARIN
FUSED
INDENODIHYDROPYRIDINE AND CHROMENO[4,3-b]QUINOLINE
DERIVATIVES
Naseem Ahmed,*a B. Venkata Babu,a Sandeep Singh,a and Petar M.
Mitrasinovicb
aDepartment of Chemistry, Indian Institute of Technology, Roorkee 247 667,
b
Uttarakhand, India. Belgrade Institute of Technology, 11018 Belgrade, Serbia
Fax:+91-1332-285745. E-mail address: nasemfcy@iitr.ernet.in
Abstract – An efficient one-pot, three-component synthesis method of highly
functionalized coumarin fused 7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]-
phenanthrene and chromeno[4,3-b]quinoline derivatives was accomplished using
aromatic aldehyde, 4-aminocoumarin and cyclic 1,3-dione in acetic acid at reflux
temperature. Environmental-friendly protocol has advantages of high yields,
creating three new bonds and one stereocenter in single operation. Further, XRD
and DFT study confirmed the molecular structure, stability and different
interaction in the crystal packing.
INTRODUCTION
Multi-component reactions (MCRs) provide a wide range of opportunities for the formation of
carbon-carbon and carbon-heteroatoms bonds in a single step for many complex and heterocyclic
molecules. MCRs are highly useful in terms of products purifications, reaction time and less use of
reagents and solvents.1 Heterocyclics have played ubiquitous scaffolds in biological, medicinal,
pharmaceutical and natural products.2 For example, many dihydropyridyl and indeno dihydropyridyl
derivatives are used as drugs in the treatment of cardiovascular diseases (calcium channel modulators)
such as amlodipine, nicardipine, s-niguldipine, 4-aza-podophyllotoxin and nifedipine (Figure 1) and some
other dihydropyridyl derivatives used as antihypertensive agents.2 Moreover, dihydropyridine derivatives
possess a variety of biological activities such as vasodilator, bronchodilator, antiatherosclerotic, antitumor,

1630
HETEROCYCLES, Vol. 85, No. 7, 2012
gastroeroprotective, hepatoprotective, and antidiabetic activities3 and various medicinal importance such as
neuroprotectant, platelet anti-aggregatory activity, cerebral anti-ischemic activity in the treatment of
Alzheimer’s disease and chemosensitizer in tumor therapy.4 In recent years, much attention has been
focused on the synthesis of 1,4-dihydropyridyl compounds due to their significant biological activity.2
4-Aryl-1,4-dihydropyridines an analogue of NADH coenzymes have been explored for their calcium
channel activity, potentiation of antitumoral, vasodilator, bronchodilator, anti-atherosclerotic, antitumor,
hepatoprotective, antidiabetic agents and antimetastatic activity of some common cytotoxic drugs.4 A
slight structural modifications on DHP rings gave a remarkable change in pharmacological effects.5
Therefore, various reaction approaches are explored using different catalysts and solvents like
[bmim]OH,6 HPAs,7 TMGT,8 MgO,9 DAHP,10 TBAB,11
DBU,12
KAl(SO4)2.12H2O,13
H6P2W18O62.18H2O,14 HY-Zeolite,15 ionic liquids, PTSA, (±)lactic acid,16 and MW-irradiation17 via
MCRs concept. However, some of these methods have limitations as longer reaction time, elevated
temperature, intolerance of functional groups, low yields and tedious workups. Therefore, an efficient and
versatile method is still required.
H
NO2
N
O
O
NO2
O
O
MeO2C
Me
Ph
MeO2C
Me
CO2Me
Me
O
2
O
N
Me
N
Me
N
MeO
OMe
H
H
OMe
nicardipine
nifedipine
NO2
4-aza-podophyllotoxin
S
N
Me
R
CO2Et
HN
O
H
R1O2C
CO2R1
Me
MeO2C
Me
X
3N
Ph
Ph
Me
N
CO2Et
N
Me
X = O, NH.
s- niguldipine
H
H
R = CF3, Ph. R1 = Me, Et
MRS 1097
Imidazo-thiazole DHP's
Figure 1. Biologically active of dihydopyridines
Similarly, coumarin and their derivatives represent most active class of compounds possessing a wide range
of biological activities. 4-Aminocoumarin and their derivatives have received considerable attention due to
different types of biological, industrial and pharmacological importance such as antibacterial, anticancer,
anti-HIV, anticoagulant, antioxidant, and spasmolytic activities. Also, 1,3-indanedione and their

HETEROCYCLES, Vol. 85, No. 7, 2012
1631
derivatives have bioactivities including antioxidants, anticoagulants, antibacterial, Cyclin-Dependent
Kinases (CDK) inhibitors, neuroprotective agent, potential antitumor agents and binding the kinase ATP
pockets.18-20 Recently, there has been incredible interest in the synthetic manipulation of biologically active
and functionalized indanedione derivatives.18-20 Previous works have also shown that fusing an indeno
moiety to the core structure of a natural products enhanced the pharmacologic potential of a target molecule.
Based on this veracity, different derivatives have been synthesized as potential drug candidates. Therefore,
different groups have tried for the synthesis of coumarin fused dihydropyridine molecules.16a,b A few
reports are also available for the synthesis of coumarin fused indenodihydropyridines and chromeno
quinolines. For example, Miri et al have synthesized chromeno[4,3-b]quinolines in multi-steps reaction
using high temperature via Michael addition followed by cyclization and dehydration.16c Recently, DHPs
synthesis has been reported using ethyl-L-lactate (solvent) and (±) lactic acid (organocatalyst) which gave
moderate yields.16d Similarly, Khan et al have synthesized DHPs using 20 mol% p-toluenesulfonic acid
(PTSA) as a catalyst in EtOH.16c,d However, reaction time is longer (7-8 h) and the product yields are
moderate to good (72-82%) at refluxed. Indeed, we need to develop an efficient and green protocol due to
the growing awareness about environmental concerns. Therefore, the organic chemists are under increasing
pressure to alter current working practices for the sustainable development in academia and industry
research and to find environmentally benign and greener alternatives.
Enormous biological important of these compounds as antagonist properties against estrogenic, tumor,
hypertensive, microbial, allergic, high affinity retinoic acid receptor and vasodilator activities and agonist
properties in potassium channel opening, fungicide and hypotensive activities motivated us to develop a
more efficient and atom-economical protocol for high yields in shorter reaction time. Herein, we describe
a simple and efficient multi-component reaction using aromatic aldehyde, 4-aminocoumarin, cyclic
1,3-diketones/indanone at reflux in acetic acid without adding catalyst or promoter to provide a series of
coumarin based DHP’s derivatives (Scheme 1).
RESULTS AND DISCUSSION
To find the optimal conditions in the synthesis of dihydropyridines, indenodihydropyridines and
chromeno quinolines, a mixture of benzaldehyde (0.8 mmol), indanone (0.8 mmol) and 4-aminocoumarin
(0.8 mmol) was refluxed for 24 h in the presence of solvents like benzene, toluene and 1,4-dioxane,
methanol, ethanol, tetrahydrofuran (THF), acetonitrile (MeCN), dimethylformamide (DMF), n-butanol
and dimethyl sulfoxide (DMSO) which gave trace amount of desired product either at room temperature
or at reflux. Reaction was further carried out in a mixture of solvents like toluene: acetic acid (9:2) &
(9:1), benzene: acetic acid (9:1), MeOH: acetic acid (9:2) ethanol:acetic acid (9:2) and acetic acid:glycol
(2:1) where acetic acid used for catalyst, gave poor to moderate product yields (Table 1, entries 12-18).

1632
HETEROCYCLES, Vol. 85, No. 7, 2012
We also tried in solvent free condition but failed to get the product. Finally, the reaction was carried out
in acetic acid at room temperature which gave trace amount of desired product, but the yields were
serendipitously increased at reflux temperature (Table 1, entries 19-20).
Table 1. Optimization of reaction conditions of 3b
S.No
1
2
3
4
5
6
7
8
Solvents
solvent free
n-BuOH
toluene
benzene
1,4-dioxane
MeCN
Time (h) & Temp (oC) Yield (%)
24, 100
30-40, 85
24, 90
24, 90
24, 90
30-40, 85
30-40, 85
30-40, 100
30-40, 85
30-40, 85
30-40, 100
24, 90
24, 90
24, 90
24, 90
24, 90
30-40, 85
24, 110
24, rt
0
0
tracea
tracea
tracea
10a
15a
17a
16a
15a
14a
8a
THF
DMSO
MeOH
EtOH
DMF
9
10
11
12 benzene:AcOH(9:1)
13 toluene:AcOH(9:1)
14 toluene:AcOH(9:2)
15 MeOH:AcOH(9:1)
16 MeOH:AcOH(9:2)
6a
10a
20a
25a
25a
35a
6
17
EtOH:AcOH(9:2)
18 AcOH:glycol (2:1)
19
20
AcOH
AcOH
2-3, 110
>90
areaction was carried out at rt and indicated temperature.
For the verification of generality of the optimal condition, different diones like indanone, dimedone and
1,3-cyclohexadione and substituted aromatic aldehydes like o-methoxybezaldehyde,
3,4,5-trimethoxybezaldehye, 2-nitrobenzaldehyde, 2,3-dimethoxybenzaldehydes, naphthaldehyde,
cinnamaldehyes and hetero-aromatic aldehydes like thiophene, furfuraldehyde were applied under
identical reaction conditions to provide the desired coumarin fused indenodihydropyridines and
chromeno[3,4-b]quinoline products (Table 2, entries 1–37). In the case of hetero-aromatic aldehydes
(furfuraldehyde and thiophene) we got good yields (Table 2, entries 12, 24, 27, 34 & 36). However,
nitrogen containing hetero-aromatic aldehydes, aliphatic aldehydes and ortho-methoxynaphthaldehydes
(Table 2, entries 38-41) were failed to give the desired product which might be due to proton (acetic
acid)-nitrogen interacting and steric hindrance in ortho-methoxynaphthaldehydes.
A pure product was obtained by recrystallization in EtOH or DMSO from the crude product in all the
reactions. All products were confirmed by their spectral analysis (IR, 1H- and 13C-NMR, and ESI-HRMS)

HETEROCYCLES, Vol. 85, No. 7, 2012
1633
and others compared with reported data in the literature.16 For example, 7-phenyl-7,13-dihydro-5-oxa-
13-aza-indeno[2,1-b]phenanthrene-6,8-dione 3a, the IR spectral peaks at 3439, 1692 cm-1 observed due
1
to NH and carbonyl groups respectively. The H NMR spectrum contained peak at δ 4.86 ppm (s, 1H)
indicated for C-4 attached dihyropyridine ring proton and δ 10.41 ppm (s, br, D2O exchangeable, 1H)
13
indicated for NH of dihyropyridine ring proton. The C NMR spectrum gave peaks at δ 191.1 ppm for
the characteristic carbonyl carbon of indanone, δ 163.9 ppm for the characteristic carbonyl carbon of
cyclic ester and δ 35.2 ppm for C-4 dihyropyridine ring carbon. Further, HRMS-ESI showed the
molecular ion peak at 400.0900 [M+.+Na] for the compound 3a. 10,10-Dimethyl-7–phenyl-
7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione 4a, the IR spectral peaks at 3307, 1681
1
cm-1 observed due to NH and carbonyl groups respectively. The H NMR spectrum contained peak at δ
4.95 ppm (s, 1H) indicated for C-4 attached DHP’s ring proton and δ 9.68 ppm (s, br, D2O exchangeable,
1H) indicated for NH of dihydropyridine ring proton. The 13C NMR spectrum gave peaks at δ 195.0 ppm
for the characteristic carbonyl carbon of indanone, δ 161.7 ppm for the characteristic carbonyl carbon of
cyclic ester, δ 34.8 ppm for C-4 dihyropyridine ring carbon and δ 29.5 & 26.9 ppm for two methyl
carbons. Further, HRMS-ESI showed the molecular ion peak at 394.1386 [M+.+Na] for the compound.
Similarly, other derivatives 3b-3l, 4b-4p & 5a-5i were confirmed on their spectral analysis (experimental
section). The structure of one of the representative compounds such as 7-(thiophen-2-yl)-7,13-dihydro-5-
oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3l) and 10,10-dimethyl-7-(4-chlorophenyl)-7,10,11,12-
tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione (4b) was further confirmed unambiguously by single
crystal X-ray diffraction analysis and DFT calculations to varify the different kind of interactions and
packing.
O
R
O
O
O
1a
O
N
H
NH2
O
3a-3l
80 - 93%
AcOH
O
O
+
R-CHO
O
R
O
reflux, 2 - 3 h
O
O
R1
R2
R1
N
H
where 1b R1, R2 = Me
1c R1, R2 = H
R2
4a - 4p
5a - 5i
86 - 94%
88 - 92%
Scheme 1. Synthesis of coumarin fused dihydropyridine derivatives

1634
HETEROCYCLES, Vol. 85, No. 7, 2012
Table 2. Derivatives of coumarin fused dihydropyridine compounds
S.No 1,3-Diketone
R
Time & Temp Product Yield(%)a
1
2
1a
1a
1a
1a
1a
1a
1a
1a
1a
1a
1a
1a
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1b
1c
1c
1c
1c
1c
1c
1c
1c
1c
benzaldehyde (2a)
p-cholrobenzaldehyde (2b)
2.5 h, 110 oC
2.2 h, 110 oC
2.3 h, 110 oC
2.7 h, 110 oC
2.9 h, 110 oC
2.5 h, 110 oC
2.8 h, 110 oC
2.9 h, 110 oC
3.0 h, 110 oC
2.7 h, 110 oC
2.9 h, 110 oC
2.4 h, 110 oC
2.0 h, 110 oC
2.1 h, 110 oC
2.3 h, 110 oC
2.9 h, 110 oC
2.9 h, 110 oC
2.5 h, 110 oC
2.8 h, 110 oC
3.0 h, 110 oC
3.0 h, 110 oC
2.7 h, 110 oC
2.8 h, 110 oC
2.4 h, 110 oC
2.7 h, 110 oC
2.9 h, 110 oC
2.6 h, 110 oC
3.0 h, 110 oC
2.2 h, 110 oC
2.3 h, 110 oC
2.8 h, 110 oC
3.0 h, 110 oC
2.8 h, 110 oC
2.8 h, 110 oC
2.9 h, 110 oC
2.7 h, 110 oC
3.0 h, 110 oC
3a
3b
3c
3d
3e
3f
3g
3h
3i
92
90
93
92
90
90
93
90
80
91
87
90
90
94
92
89
86
90
91
88
86
87
89
90
90
92
91
91
92
90
91
89
90
91
88
90
91
0
3
4
5
6
7
8
9
p-tolualdehyde (2c)
4-methoxybenzaldehyde (2d)
2-methoxybenzaldehyde (2e)
1-naphthaldehyde (2f)
4-hydroxybenzaldehyde (2g)
3,4-dimethoxybenzaldehyde (2h)
3,4,5-trimethoxybenzaldehyde (2i)
2-nitrobenzaldehyde (2j)
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
3j
3k
3l
3-nitrobenzaldehyde (2k)
thiophene-2-carbaldehyde (2l)
benzaldehyde (2a)
p-cholrobenzaldehyde (2b)
p-tolualdehyde (2c)
4-methoxybenzaldehyde (2d)
2-methoxybenzaldehyde (2e)
1-naphthaldehyde (2f)
4a
4b
4c
4d
4e
4f
4g
4h
4i
4-hydroxybenzaldehyde (2g)
3,4-dimethoxybenzaldehyde (2h)
3,4,5-trimethoxybenzaldehyde (2i)
2-nitrobenzaldehyde (2j)
4j
4k
4l
3-nitrobenzaldehyde (2k)
thiophene-2-carbaldehyde (2l)
2-nitrobenzaldehyde (2m)
2-hydroxybenzaldehyde (2n)
furan-2-carbaldehyde (2o)
cinnamaldehyde (2p)
4m
4n
4o
4p
5a
5b
5c
5d
5e
5f
benzaldehyde (2a)
1-naphthaldehyde (2f)
4-hydroxybenzaldehyde (2g)
3,4,5-trimethoxybenzaldehyde (2i)
3-nitrobenzaldehyde (2k)
thiophene-2-carbaldehyde (2l)
2-hydroxybenzaldehyde (2n)
furan-2-carbaldehyde (2o)
cinnamaldehyde (2p)
5g
5h
5i
1a, 1b, 1c 2-methoxy-1-naphthaldehyde (2q) 30-40 h, rt-110 oC
---b
---b
---b
---b
1a, 1b, 1c
1a, 1b, 1c
1a, 1b, 1c
1H-pyrrole-2-carbaldehyde (2r) 30-40 h, rt-110 oC
0
0
0
nicotinaldehyde (2s)
MeCHO (2t)
30-40 h, rt-110 oC
24 h, rt-110 oC
a Isolated yield of the DHP’s. b No product formation even increase in reaction time.

HETEROCYCLES, Vol. 85, No. 7, 2012
1635
Comparison of Experimental and Computational Structures
To evaluate the stereochemical quality of the X-ray structures, the optimized structures of the compounds
are generated using density functional theory (DFT). The full unconstrained geometry optimizations are
carried out with the B3LYP/6-311++G(d,p) hybrid DFT method using the GAUSSIAN 98 suite of
programs.21 A combination of Becke’s three-parameter hybrid exchange functional,22 as implemented in
GAUSSIAN 98,23 and the Lee-Yang-Parr correlation functional24 gives the B3LYP functional. The most
attractive DFT method - B3LYP was generally found capable of generating reliable geometries of the
large systems containing several aromatic rings.25,26
The X-ray and computational structures of the compound containing sulphur are given in Figure 2. The
estimated energies showed that the DFT structure is more stable by about 39.72 kcal/mol than the
experimental one. The major structural distinction is the different spatial orientation of the S-containing
aromatic ring with respect to the remainder of the molecule (Figure 2). A close inspection of the structural
parameters given in Table 5 illustrates that the structural difference is not obvious by only considering the
bond lengths and the interatomic angles. However, values of several critical dihedral angles, such as
C25-C24-C11-C12, C25-C24-C11-C7, S28-C24-C11-C7 and S28-C24-C11-C12 (Table 5), rationalize
the structural deviations of these two structures.
S
O
O
O
N
H
3l
Figure 2. Experimental X-ray (left) and Computational - B3LYP/6-311++G(d,p) (right) 3D models of
7-(Thiophen-2-yl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3l)
The X-ray and computational structures of the compound containing chlorine are given in Figure 3. The
evaluated energies demonstrate that the experimental structure is energetically less favorable by about
204.57kcal/mol than the DFT structure. The bonding distances in the DFT 3D model are in general larger
than the experimental ones (Table 6). The major structural distinction is the different spatial orientation of
one of the two methyl groups relative to the rest of the molecule (Figure 3). A close inspection of the
structural parameters given in Table 6 illustrates that the reported values of several critical dihedral angles
rationalize the structural deviations between these two structures.

1636
HETEROCYCLES, Vol. 85, No. 7, 2012
Cl
O
O
O
N
4bH
Figure 3. Experimental X-ray (left) and Computational - B3LYP/6-311++G(d,p) (right) 3D models of
10,10-Dimethyl-7-(4-chlorophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione (4b)
Cl
S
O
O
O
O
O
O
N
H
N
4bH
3l
Figure 4. ORTEP diagrams of 7-(Thiophen-2-yl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-
6,8-dione (3l) and 10,10-Dimethyl-7-(4-chlorophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]-quino-
line-6,8-dione (4b)
Description of crystal structure:
Compounds 3l and 4b crystallize with one solvent molecule of DMSO in asymmetric unit (Figure 4). The
crystal packing of 3l shows that two organic molecules are hydrogen bonded with two molecules of
DMSO via strong N1-H1…O4, 1.959(20) Å; and weak S2…O1, 3.304(48) Å non-covalent interactions,
while in 4b, one molecule strongly interacted with one molecule of DMSO through N1-H1…O4,
2.050(13) Å hydrogen bond interactions (Figure 5).

HETEROCYCLES, Vol. 85, No. 7, 2012
1637
Table 3. Selected hydrogen-bond parameters
D-H···A d(D-H) d(H-A)
Figure 3 (3l)
d(D-A) <(DHA)>
N1-H1···O4 0.860 1.959(20)
Figure 3 (4b)
2.807
2.891
168.4
165.5
N1-H1···O4 0.861 2.050(13)
Figure 5. Intramolecular hydrogen-bonding between solvent and molecule of 3l and 4b
The possible mechanism is given in Scheme 2. Initially, the condensation of aromatic aldehyde (I) with
1,3-diketone (II) gave Knoevenagel product, benzylidenecyclohexane-1,3-dione (IV), which may act as
Michael acceptor. Then, intermediate IV reacts with 4-aminocoumarin (III) to provide reactive
intermediate (V), which undergoes intramolecular ring closure followed by dehydration to give the
desired coumarin fused indenodihydropyridines or chromeno [4,3-b]quinoline derivatives (VI).
Scheme 2. Plausible mechanism

1638
HETEROCYCLES, Vol. 85, No. 7, 2012
CONCLUSION
In conclusion, we have demonstrated a simple and highly efficient method for the synthesis of coumarin
fused DHP’s in a one-pot, three components reaction protocol. The current environmentally benign
procedure is a near absolute green protocol as follows: (i) it does not require the any use of catalysts and
purification steps such as column chromatography; (ii) it requires less time to obtain the products; (iii) it
incorporates the reactants into the final product to a maximum possible extent without any side products.
We also reported XRD study and calculated DFT 3D models of computational studies of products 3l and
4b for the molecular structure, stability and different interactions in the crystal packing.
EXPERIMENTAL
General Methods: Commercially available reagents were used without further purification unless
mentioned. All reactions were monitored by TLC using pre-coated silica gel aluminum plates.
Visualization of TLC plates was accomplished with UV lamp or in iodine chamber. Melting points were
recorded on perfit apparatus and are uncorrected. IR spectra of the compounds were expressed as wave
1
13
1
numbers (cm-1). H and C NMR spectra were recorded at 500 and 125 MHz, respectively. H NMR
1
spectra were recorded in DMSO-d6 and it self an internal standard. Chemical shifts of H NMR spectra
were given in parts per million and the coupling constant J was measured in Hz. Data are reported as
follows: chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd =
double doublet). Mass spectra were recorded by HRMS-ESI. The X-ray data collection were performed on
a Bruker Kappa Apex four circle-CCD diffractometer using graphite monochromated MoKα radiation (λ =
0.71070 Å) at 100 K. Images were created in the crystal lattice with DIAMOND software.
General Procedure (a) Synthesis of indenodihydropyridine: A mixture of a selected aldehyde (0.8 mmol),
4-aminocoumarin (0.8 mmol), and indanone (0.8 mmol) was suspended in 6 mL acetic acid. The
suspension was slowly dissolved and converted into a yellow solution upon heating at 110 oC. After 1.2 h, a
bright orange precipitate started to form. After 2-3 h of heating the reaction mixture is cooled to room
temperature and the orange precipitate is filtered off. Then, it was washed with 6 mL of EtOH followed by
3 mL Et2O. Pure products were obtained in 80-94% yields after crystallization in EtOH or DMSO.
(b) Synthesis of 4-aminocoumarins: A mixture of well powdered 4-hydroxycoumarin (1.07 g, 0.066 mol)
and ammonium acetate (7.87 g, 0.1 mol) was melted in an oil bath (max. 130 ºС). Liquid mixture was
stirred for 3 h and was left to cool to ambient temperature. After cooling, water was added and the crude
product was isolated as yellow crystals by simple filtration. Further purification was done by dissolving the
crystals in EtOH followed by water addition gave the precipitate, filtered and dried under vacuum.
7-Phenyl-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3a):

HETEROCYCLES, Vol. 85, No. 7, 2012
1639
o
Orange colour solid. Yield: 92%. Mp 330-332 C. IR νmax (KBr, cm-1): 3439 (NH str), 2942 (aromatic
C-H str), 1692 (C=O str), 1628, 1503 (aromatic, C=C str), 1402, 1128. 1H-NMR (DMSO-d6, 500 M Hz) δ
(ppm): 10.41 (s, br, D2O exchangeable, 1H), 8.53 (d, J=8.0 Hz, 1H), 8.09 (d, J=6.5 Hz, 1H), 7.99 (m,
1H), 7.68 (d, J=8.0 Hz, 1H), 7.51 (t, J=8.0 Hz, 2H), 7.42 (d, J=7.5 Hz, 1H), 7.39 (d, J=7.0 Hz, 1H), 7.29
(d, J=6.5 Hz, 2H), 7.13 (d, J=8.5 Hz, 3H), 4.86 (s, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.1,
163.9, 154.1, 151.9, 144.8, 143.0, 138.0, 136.4, 132.5, 132.2, 130.2, 128.2, 127.85, 126.49, 125.41,
123.83, 120.51, 116.80, 116.73, 114.49, 113.39, 109.93, 103.86, 35.23. HRMS-ESI (m/z): [M+.+Na]
calcd for C25H15NO3: 400.0950; found 400.0900.
7-(4-Chlorophenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3b):
o
Orange colour solid. Yield: 90%. Mp 325-327 C. IR νmax (KBr, cm-1): 3439 (NH str), 2977 (aromatic
C-H str), 1693 (C=O str), 1623, 1581 (aromatic, C=C str), 1511, 1425, 1161, 1058. 1H-NMR (DMSO-V,
500 MHz) δ (ppm): 10.43 (s, br, D2O exchangeable, 1H), 8.29 (d, J=7.5 Hz, 1H), 8.01 (d, J=7.5 Hz,
1H), 7.69 (t, J=7.5 Hz, 1H), 7.51 (m, 2H), 7.42 (d, J=8.0 Hz, 1H), 7.37 (t, J=8.0 Hz, 1H), 7.30 (m, 5H),
13
4.84 (s, 1H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.1, 160.1, 153.7, 151.9, 143.7, 143.3, 136.3,
132.4, 132.2, 132.1, 130.3, 129.8, 128.1, 124.2, 123.6, 120.8, 120.7, 116.9, 113.4, 109.4, 103.4, 34.9.
HRMS-ESI (m/z): [M+.] calcd for C25H14NClO4: 411.0662; found 411.0652.
7-(p-Tolyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3c):
o
Orange colour solid. Yield: 93%. Mp above 360 C. IR νmax (KBr, cm-1): 3432 (NH str), 2953 (aromatic
C-H str), 1690 (C=O str), 1627, 1503 (aromatic, C=C str), 1401, 1183, 1129, 1003. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 10.34 (s, br, D2O exchangeable, 1H), 8.52 (d, J=8.0 Hz, 1H), 8.00 (d, J=7.0 Hz, 1H),
7.69 (t, J=7.5 Hz, 1H), 7.51 (t, J=7.5 Hz, 2H), 7.42 (d, J=8.0 Hz, 2H), 7.37 (t, J=7.5 Hz, 1H), 7.30 (d,
J=7.0 Hz, 2H),7.17 (d, J=7.5 Hz, 1H), 7.03 (d, J=7.5 Hz, 1H), 4.85 (s, 1H), 2.20 (s, 3H). 13C NMR
(DMSO-d6, 125 MHz) δ (ppm): 191.2, 160.2, 153.5, 151.9, 142.9, 141.9, 136.4, 135.6, 132.6, 132.5,
132.2, 132.1, 130.2, 128.7, 127.7, 124.0, 123.5, 116.8, 113.5, 110.0, 104.0, 34.8, 20.5. HRMS-ESI (m/z):
[M+Na+.] calcd for C26H17NO3: 414.1106; found 414.1075.
7-(4-Methoxyphenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3d):
o
Orange colour solid. Yield: 92%. Mp 310-312 C. IR νmax (KBr, cm-1): 3422 (NH str), 3157, 2957
1
(aromatic C-H str), 1691 (C=O str), 1627, 1502 (aromatic, C=C str), 1400, 1130, 1004. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 10.41 (s, br, D2O exchangeable, 1H), 8.53 (d, J=7.5 Hz, 1H), 8.00 (d, J=
6.5 Hz, 1H), 7.69 (d, J=8.0 Hz, 1H), 7.52 (t, J=8.0 Hz, 2H), 7.43 (d, J=7.5 Hz, 1H), 7.36 (d, J=7.0 Hz,
1H), 7.30 (d, J=6.5 Hz, 1H), 7.19 (d, J=6.5 Hz, 2H), 6.79 (d, J=7.5 Hz, 2H), 4.82 (s, 1H), 3.66 (s, 3H).

1640
HETEROCYCLES, Vol. 85, No. 7, 2012
13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.4, 160.2, 157.9, 153.4, 151.8, 142.7, 137.0, 136.4, 132.4,
132.2, 130.2, 128.9, 124.1, 123.4, 120.8, 120.5, 116.8, 113.6, 113.4, 110.1, 104.2, 54.9, 34.3. HRMS-ESI
(m/z): [M+Na+.] calcd for C26H17NO4: 430.1055; found 430.1035.
7-(2-Methoxyphenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3e):
o
Orange colour solid. Yield: 90%. Mp 332-334 C. IR νmax (KBr, cm-1): 3427 (NH str), 2954 (aromatic
1
C-H str), 1701 (C=O str), 1655, 1611 (aromatic, C=C str), 1451, 1354, 1100. H-NMR (DMSO-d6, 500
MHz) δ (ppm): 10.35 (s, br, D2O exchangeable, 1H), 8.53 (d, J=7.5 Hz, 1H), 7.98 (d, J=6.5 Hz, 1H), 7.67
(d, J=8.0 Hz, 1H), 7.51 (t, J=8.0 Hz, 2H), 7.41 (d, J=7.5 Hz, 1H), 7.35 (t, J=7.0 Hz, 1H), 7.24 (d, J=6.5
Hz, 1H), 7.20 (d, J=6.5 Hz, 1H), 7.11 (d, J=6.5 Hz, 1H), 6.90 (d, J=7.5 Hz, 1H), 6.82 (d, J=6.5 Hz, 1H),
5.10 (s, 1H), 3.64 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.4, 160.4, 157.9, 154.5, 152.3,
143.8, 136.9, 133.0, 132.9, 132.4, 132.3, 130.7, 130.4, 128.3, 124.4, 123.7, 120.9, 120.6, 120.6, 117.2,
113.8, 109.7, 103.9, 56.3, 31.7. HRMS-ESI (m/z): [M+Na+.] calcd for C26H17NO4: 430.1055; found
430.1025.
7-(Naphthalen-1-yl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3f):
Orange solid. Yield: 90%. Mp above 360 oC. IR νmax (KBr, cm-1): 3430 (NH str), 2946 (aromatic C-H str),
1
1679 (C=O str), 1541 (aromatic, C=C str), 1436, 1342, 1128, 1037. H-NMR (DMSO-d6, 500 MHz) δ
(ppm): 10.45 (s, br, D2O exchangeable, 1H), 8.64 (d, J=8.0 Hz, 1H), 8.59 (dd, J=8.0, 1.0 Hz, 1H), 8.02 (d,
J=7.5 Hz, 1H), 7.87 (d, J=15.0 Hz, 1H), 7.71 (m, 2H), 7.59 (t, J=7.0 Hz, 1H), 7.52 (m, 3H), 7.49 (d, J=
13
8.0 Hz, 1H), 7.34 (m, 3H), 7.71 (d, J=7.0 Hz, 1H), 5.66 (s, 1H). C NMR (DMSO-d6, 125 MHz) δ
(ppm): 191.4, 160.5, 153.3, 152.3, 143.4, 136.9, 133.3, 132.8, 132.6, 132.5, 131.2, 130.5, 128.4, 127.4,
126.1, 126.0, 125.1, 124.4, 123.9, 120.9, 117.2, 113.8, 111.5, 105.6, 34.2. HRMS-ESI (m/z): [M+Na+.]
calcd for C29H17NO3: 450.1106; found 450.1063.
7-(4-Hydroxyphenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3g):
o
Orange colour solid. Yield: 93%. Mp above 360 C. IR νmax (KBr, cm-1): 3422, 3410 (NH str), 2951
1
(aromatic C-H str), 1698 (C=O str), 1635, 1528 (aromatic, C=C str), 1417, 1140, 1031. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 10.37 (s, br, D2O exchangeable, 1H), 9.24 (s, br, D2O exchangble, 1H),
8.52 (d, J=8.0 Hz, 1H), 7.99 (d, J=6.5 Hz, 1H), 7.69 (d, J=8.0 Hz, 1H), 7.52 (t, J=8.0 Hz, 2H), 7.43 (d,
J=7.5 Hz, 1H), 7.36 (d, J=7.0 Hz, 1H), 7.30 (d, J=6.5 Hz, 1H), 7.05 (d, J=8.5 Hz, 2H), 6.61 (d, J=8.5 Hz,
2H), 4.76 (s, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.7, 160.6, 156.4, 153.7, 152.3, 142.9,
136.9, 135.8, 132.9, 132.5, 130.5, 129.2, 124.4, 123.8, 121.1, 120.8, 117.2, 115.3, 113.9, 110.7, 104.7,
34.6. HRMS-ESI (m/z): [M+Na+.] calcd for C25H15NO4: 416.0899; found 416.0817.

HETEROCYCLES, Vol. 85, No. 7, 2012
1641
7-(3,4-Dimethoxyphenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3h):
o
Orange colour solid. Yield: 90%. Mp 306-308 C. IR νmax (KBr, cm-1): 3439 (NH str), 2941 (aromatic
C-H str), 1692 (C=O str), 1628, 1503 (aromatic, C=C str), 1403, 1129. 1H-NMR (DMSO-d6, 500 M Hz)
δ (ppm): 10.43 (s, br, D2O exchangeable, 1H), 8.53 (d, J=7.5 Hz, 1H), 8.00 (d, J=7.0 Hz, 1H), 7.71 (d,
J= 8.0 Hz, 1H), 7.54 (t, J=7.5 Hz, 2H), 7.44 (d, J=8.0 Hz, 1H), 7.38 (t, J=7.5 Hz, 1H), 7.32 (d, J=7.0 Hz,
1H), 6.94 (m, 1H), 6.79 (d, J=8.5 Hz, 1H), 6.70 (dd, J=8.5, 2.0 Hz, 1H), 4.83 (s, 1H), 3.69 (s, 3H), 3.65
(s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.4, 160.2, 151.9, 148.3, 147.6, 137.5, 132.2, 130.2,
124.1, 123.5, 120.8, 120.5, 119.6, 116.8, 112.1, 111.8, 55.5, 34.6. HRMS-ESI (m/z): [M+Na+.] calcd for
C27H19NO5: 460.1161; found 460.1181.
7-(3,4,5-Trimethoxyphenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3i):
o
Orange colour solid. Yield: 80%. Mp 346-348 C. IR νmax (KBr, cm-1): 3423 (NH str), 3134, 2955
1
(aromatic C-H str), 1692 (C=O str), 1635, 1590 (aromatic, C=C str), 1500, 1455, 1177, 1123. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 10.47 (s, br, D2O exchangeable, 1H), 8.52 (d, J=7.5 Hz, 1H), 7.99 (d, J=
7.0 Hz, 1H), 7.70 (t, J=7.5 Hz, 1H), 7.53 (t, J=7.5 Hz, 1H), 7.44 (d, J=8.0 Hz, 1H), 7.38 (t, J=8.0 Hz,
2H), 7.32 (d, J=7.0 Hz, 1H), 6.54 (s, 2H), 4.85 (s, 1H), 3.67 (s, 6H), 3.58 (s, 3H). 13C NMR (DMSO-d6,
125 MHz) δ (ppm): 191.3, 160.3, 152.6, 151.9, 140.3, 136.4, 136.3, 132.5, 132.3, 132.2, 130.3, 124.0,
123.6, 120.8, 120.6, 116.8, 113.4, 109.6, 105.3, 103.5, 59.8, 55.8, 35.4. HRMS-ESI (m/z): [M+Na+.]
calcd for C28H21NO6: 490.1267; found 490.1235.
7-(2-Nitrophenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3j):
o
Orange colour solid. Yield: 91%. Mp above 360 C. IR νmax (KBr, cm-1): 3425 (NH str), 2985 (aromatic
C-H str), 1703 (C=O str), 1624, 1522 (aromatic, C=C str), 1479, 1358, 1197, 1033. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 10.44 (s, br, D2O exchangeable, 1H), 8.55 (d, J=8.0 Hz, 1H), 8.05 (d, J=7.0 Hz, 1H),
7.86 (d, J=8.0 Hz, 1H), 7.70 (t, J=7.5 Hz, 1H), 7.57-7.51 (m, 4H), 7.40-7.37 (m, 3H), 7.29 (m, 1H), 5.84
(s, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 190.7, 160.1, 152.0, 148.6, 143.6, 138.8, 136.2, 133.4,
132.5, 132.2, 131.4, 130.5, 127.7, 124.1, 123.9, 123.7, 120.8, 116.9, 113.2, 108.6, 103.5, 30.5.
HRMS-ESI (m/z): [M+Na+.] calcd for C25H14N2O5: 416.0899; found 416.0817.
7-(3-Nitrophenyl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3k):
Orange colour solid. Yield: 87%. Mp above 360 oC. IR νmax (KBr, cm-1): 3435 (NH str), 2938 (aromatic
C-H str), 1691 (C=O str), 1614, 1515 (aromatic, C=C str), 1400, 1347, 1187, 1029. 1H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 10.52 (s, br, D2O exchangeable, 1H), 8.57 (d, J=6.0 Hz, 1H), 8.10 (d, J=
6.5 Hz, 1H), 8.05 (m, 2H), 7.81 (d, J=8.0 Hz, 1H), 7.73 (m, 1H), 7.56 (d, J=6.0 Hz, 1H), 7.45 (d, J=7.5

1642
HETEROCYCLES, Vol. 85, No. 7, 2012
Hz, 1H), 7.41 (m, 2H), 7.34 (m, 2H), 5.10 (s, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.0, 160.1,
153.9, 152.1, 147.7, 146.6, 143.7, 136.1, 134.7, 132.5, 132.3, 132.2, 130.4, 129.7, 124.1, 123.7, 122.4,
121.4, 120.9, 120.8, 116.9, 113.3, 108.8, 102.9, 35.5. HRMS-ESI (m/z): [M+Na+.] calcd for C25H14N2O4:
445.0800; found 445.0790.
7-(Thiophen-2-yl)-7,13-dihydro-5-oxa-13-aza-indeno[2,1-b]phenanthrene-6,8-dione (3l):
o
Orange colour solid. Yield: 90%. Mp 330-332 C. IR νmax (KBr, cm-1): 3422 (NH str), 2968 (aromatic
C-H str), 1690 (C=O str), 1627, 1502 (aromatic, C=C str), 1401, 1181, 1130, 1003. 1H-NMR (DMSO-d6,
500 M Hz) δ (ppm): 10.58 (s, br, D2O exchangeable, 1H), 8.50 (d, J=8.0 Hz, 1H), 8.00 (d, J=7.0 Hz, 1H),
7.71 (t, J=8.0 Hz, 1H), 7.53 (t, J=7.0 Hz, 2H), 7.40 (d, J=8.0 Hz, 1H), 7.37 (d, J=7.0 Hz, 2H), 7.27 (d,
J=7.0 Hz, 1H), 6.89 (m, 2H), 5.19 (d, J=2.0 Hz, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 191.1,
160.3, 151.8, 148.5, 132.5, 132.3, 130.5, 127.0, 124.7, 124.5, 124.2, 123.5, 121.1, 120.8, 116.9, 109.1,
103.6, 54.8, 29.6. HRMS-ESI (m/z): [M+.] calcd for C23H13NSO3: 383.0616; found 383.0601.
10,10-Dimethyl-7-phenyl-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione (4a):
Light yellow solid. Yield: 90%. Mp 290-292 oC. IR νmax (KBr, cm-1): 3307 (NH str), 2956 (aromatic C-H
str), 1681 (C=O str), 1505 (aromatic, C=C str), 1473, 1356, 1195, 1051. 1H-NMR (DMSO-d6, 500 M Hz)
δ (ppm): 9.68 (s, br, D2O exchangeable, 1H), 8.30 (d, J=8.0 Hz, 1H), 7.62 (t, J=8.0 Hz, 1H), 7.42 (t,
J=8.0 Hz, 1H), 7.36 (d, J=7.5 Hz, 1H), 7.24-7.10 (m, 4H), 7.09 (t, J=7.0 Hz, 1H), 4.95 (s, 1H), 2.65 (m,
13
2H), 2.26 (d, J=16.0 Hz, 1H), 2.07 (d, J=16.0 Hz, 1H), 1.06 (s, 3H), 0.93 (s, 3H). C NMR (DMSO-d6,
125 MHz) δ (ppm): 195.0, 161.7, 152.4, 150.0, 146.2, 132.3, 128.4, 128.1, 126.6, 124.4, 123.3, 117.3,
113.4, 111.2, 50.5, 34.8, 32.6, 29.5, 26.9. HRMS-ESI (m/z): [M+Na+.] calcd for C24H21NO3: 394.1419;
found 394.1406.
10,10-Dimethyl-7-(4-chlorophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4b):
Light yellow solid. Yield: 94%. Mp 216-218 oC. IR νmax (KBr, cm-1): 3422 (NH str), 2957 (aromatic C-H
str), 1705 (C=O str), 1606 (aromatic, C=C str), 1476, 1365, 1195, 1045. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.73 (s, br, D2O exchangeable, 1H), 8.32 (d, J=8.0 Hz, 1H), 7.65 (t, J=8.0 Hz, 1H), 7.46 (t,
J=8.0 Hz, 1H), 7.39 (d, J=8.0 Hz, 1H), 7.28-7.24 (m, 4H), 4.96 (s, 1H), 2.66 (d, J=8.0 Hz, 1H), 2.10 (d,
J=8.0 Hz, 1H), 1.08 (s, 3H), 0.94 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.0, 160.6, 152.5,
150.2, 145.1, 142.7, 132.4, 131.2, 130.0, 128.3, 124.4, 123.4, 117.3, 113.3, 110.9, 101.8, 50.4, 34.6, 32.5,
29.4, 26.9. HRMS-ESI (m/z): [M+Na+.] calcd for C24H20NClO3: 428.1029; found 428.1004.

HETEROCYCLES, Vol. 85, No. 7, 2012
1643
10,10-Dimethyl-7-(p-tolyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione(4c):
o
Light yellow colour solid. Yield: 92%. Mp 330-332 C. IR νmax (KBr, cm-1): 3445 (NH str), 3128, 2985
1
(aromatic C-H str), 1685 (C=O str), 1640, 1593 (aromatic, C=C str), 1505, 1463, 1152, 1093. H-NMR
(DMSO-d6, 500 M Hz) δ (ppm): 9.65 (s, br, D2O exchangeable, 1H), 8.29 (d, J=7.5 Hz, 1H), 7.63 (t,
J=8.0 Hz, 1H), 7.43 (t, J=7.5 Hz, 1H), 7.37 (d, J=7.5 Hz, 1H), 7.10 (d, J=8.0 Hz, 2H), 6.99 (d, J=8.0
Hz, 2H), 4.90 (s, 1H), 2.65 (m, 2H), 2.25 (d, J=16.0 Hz, 1H), 2.18 (s, 3H), 2.06 (d, J=16.0 Hz, 1H), 1.06
(s, 3H), 0.94 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.8, 160.3, 151.9, 149.5, 142.9, 141.9,
135.4, 131.9, 128.5, 127.6, 124.0, 122.8, 116.8, 112.9, 110.9, 101.9, 50.1, 33.9, 32.1, 29.2, 26.5, 20.5.
HRMS-ESI (m/z): [M+Na+.] calcd for C25H23NO3: 408.1576; found 408.1509.
10,10-Dimethyl-7-(4-methoxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4d):
Light yellow solid. Yield: 89%. Mp 260-262 oC. IR νmax (KBr, cm-1): 3444 (NH str), 2946 (aromatic C-H
str), 1656 (C=O str), 1511 (aromatic, C=C str), 1471, 1367, 1192, 1040. 1H-NMR (DMSO-d6, 500 M Hz)
δ (ppm): 9.65 (s, br, D2O exchangeable, 1H), 8.29 (d, J=8.0 Hz, 1H), 7.62 (d, J=8.5 Hz, 1H), 7.43 (m,
1H), 7.37 (d, J=8.0 Hz, 1H), 7.13 (d, J=8.5, 2H), 6.75 (d, J=8.5 Hz, 2H), 4.88 (s, 1H), 3.65 (s, 3H), 2.64
13
(m, 2H), 2.25 (d, J=16.0 Hz, 1H), 2.07 (d, J=16.0 Hz, 1H), 1.06 (s, 3H), 1.05 (s, 3H). C NMR
(DMSO-d6, 125 MHz) δ (ppm): 195.1, 160.7 (C=O), 158.0, 152.4, 149.8, 142.2, 138.5, 132.3, 129.1,
124.4, 123.3, 117.2, 113.7, 113.4, 111.4, 102.5, 55.3, 50.5, 33.9, 32.6, 29.5, 26.9. HRMS-ESI (m/z):
[M+Na+.] calcd for C25H23NO4: 424.1525; found 424.1505.
10,10-Dimethyl-7-(2-methoxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4e):
o
Light yellow solid. Yield: 86%. Mp 302-304 C. IR νmax (KBr, cm-1): 3435 (NH str), 3296, 2950
1
(aromatic C-H str), 1704 (C=O str), 1602 (aromatic, C=C str), 1476, 1358, 1242, 1192, 1016. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 9.62 (s, br, D2O exchangeable, 1H), 8.29 (d, J=7.0 Hz, 1H), 7.60 (m, 1H),
7.43 (m, 1H), 7.33 (d, J=8.5 Hz, 1H), 7.26 (dd, J=7.5 Hz, 1.5 Hz, 1H), 7.08 (d, J=6.0 Hz, 1H), 6.84 (d,
J=8.5 Hz, 1H), 6.79 (m, 1H), 5.04 (s, 1H), 3.62 (s, 3H), 2.67 (m, 2H), 2.23 (d, J=16.0 Hz, 1H), 1.98 (d,
J=16.0 Hz, 1H), 1.05 (s, 3H), 1.04 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.85, 160.46
(C=O), 158.4, 152.4, 150.4, 142.9, 132.7, 132.1, 132.0, 127.9, 124.3, 123.1, 119.8, 117.1, 113.5, 111.8,
109.6, 100.8, 55.7, 50.6, 33.5, 32.4, 29.7, 26.3. HRMS-ESI (m/z): [M+Na+.] calcd for C25H23NO4:
424.1525; found 424.1501.
10,10-Dimethyl-7-(naphthalen-1-yl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione

1644
HETEROCYCLES, Vol. 85, No. 7, 2012
(4f):
Light yellow solid. Yield: 90%. Mp 320-322 oC. IR νmax (KBr, cm-1): 3445 (NH str), 2958 (aromatic C-H
str), 1677 (C=O str), 1510 (aromatic, C=C str), 1472, 1362, 1194, 1055. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.76 (s, br, D2O exchangeable, 1H), 8.79 (d, J= 8.0 Hz, 1H), 8.36 (d, J=8.0 Hz, 1H), 7.81 (d,
J=8.0 Hz, 1H), 7.68 (d, J=8.0 Hz, 1H), 7.61 (d, J=7.0 Hz, 1H), 7.56 (d, J=8.0 Hz, 1H), 7.49-7.44, (m,
2H), 7.35 (t, J=7.0 Hz, 3H), 5.73 (s, 1H), 2.70 (m, 2H), 2.24 (d, J=8.0 Hz, 1H), 1.97 (d, J=8.0 Hz, 1H)
13
1.07 (s, 3H), 0.88 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.1, 160.7, 152.2, 149.5, 145.5,
142.2, 133.2, 132.2, 131.2, 128.0, 127.2, 126.9, 126.0, 125.9, 125.9, 125.7, 124.4, 123.3, 117.2, 113.5,
112.9, 103.8, 50.4, 32.5, 29.6, 26.7. HRMS-ESI (m/z): [M+Na+.] calcd for C28H23NO3: 444.1576; found
444.1505.
10,10-Dimethyl-7-(4-hydroxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4g):
Light yellow solid. Yield: 91%. Mp 346-348 oC. IR νmax (KBr, cm-1): 3270 (NH str), 2957 (aromatic C-H
str), 1672 (C=O str), 1619 (aromatic, C=C str), 1469, 1366, 1197, 1046. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.62 (s, br, D2O exchangeable, 1H), 9.12 (s, br, D2O exchangeable, 1H), 8.27 (d, J=8.0 Hz, 1H),
7.61 (d, J=7.5 Hz, 1H), 7.44 (d, J=8.0 Hz, 1H), 7.37 (d, J=8.5 Hz, 1H), 7.01 (d, J=8.5 Hz, 2H), 6.57 (d,
J=8.5 Hz, 2H), 4.84 (s, 1H), 2.63 (m, 2H), 2.24 (d, J=16.0 Hz, 1H), 2.08 (d, J=16.0 Hz, 1H), 1.06 (s, 3H),
13
0.95 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.1, 160.7 (C=O), 156.1, 152.3, 149.6, 142.0,
136.9, 132.1, 129.1, 124.3, 123.2, 117.2, 115.1, 113.5, 111.6, 102.7, 50.6, 33.7, 32.5, 29.5, 26.9.
HRMS-ESI (m/z): [M+Na+.] calcd for C24H23NO4: 410.1368; found 410.1311.
10,10-Dimethyl-7-(3,4-dimethoxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-
dione (4h):
o
Light yellow solid. Yield: 88%. Mp 288-290 C. IR νmax (KBr, cm-1): 3444 (NH str), 3231, 2947
1
(aromatic C-H str), 1681 (C=O str), 1609 (aromatic, C=C str), 1402, 1361, 1236, 1171, 1026. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 9.67 (s, br, D2O exchangeable, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.61 (m, 1H),
7.42 (m, 1H), 7.35 (d, J=8.5 Hz, 1H), 6.85 (m, 1H), 6.67 (d, J=8.5 Hz, 1H), 6.69 (d, J=8.0 Hz, 1H), 4.89
(s, 1H), 3.66 (s, 3H), 3.65 (s, 3H), 2.66 (m, 2H), 2.11 (d, J=16.0 Hz, 1H), 1.91 (d, J=16.0 Hz, 1H), 1.07
(s, 3H), 0.99 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.2, 160.5 (C=O), 152.4, 149.9, 148.5,
147.7, 142.2, 138.8, 132.2, 124.4, 123.3, 119.9, 117.2, 113.5, 112.3, 111.9, 111.2, 102.4, 55.7, 55.7, 50.5,
34.0, 32.5, 29.5, 26.8. HRMS-ESI (m/z): [M+Na+.] calcd for C26H25NO5: 454.1630; found 454.1611.
10,10-Dimethyl-7-(3,4,5-trimethoxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-

HETEROCYCLES, Vol. 85, No. 7, 2012
1645
6,8-dione (4i):
o
Light yellow solid. Yield: 86%. Mp 300-302 C. IR νmax (KBr, cm-1): 3436 (NH str), 3227, 2940
1
(aromatic C-H str), 1705 (C=O str), 1622 (aromatic, C=C str), 1474, 1359, 1122, 1013. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 9.73 (s, br, D2O exchangeable, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.63 (t,
J=8.0 Hz, 1H), 7.43 (t, J=8.0 Hz, 1H), 7.37 (d, J=7.5 Hz, 1H), 6.52 (s, 2H), 4.92 (s, 1H), 3.67 (s, 6H),
3.57 (s, 3H), 2.69 (d, J=5.0 Hz, 2H), 2.28 (d, J=16.0 Hz, 1H), 2.10 (d, J=16.0 Hz, 1H), 1.09 (s, 3H), 1.07
(s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.1, 160.8 (C=O), 152.8, 152.3, 150.4, 142.2, 141.6,
136.5, 132.3, 124.4, 123.3, 117.2, 113.4, 110.7, 105.4, 102.2, 60.2, 56.1, 50.5, 34.7, 32.5, 29.6, 26.8.
HRMS-ESI (m/z): [M+Na+.] calcd for C27H27NO6: 484.1736; found 484.1712.
10,10-Dimethyl-7-(2-nitrophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4j):
o
Yellow colour solid. Yield: 87%. Mp 260-262 C. IR νmax (KBr, cm-1): 3439 (NH str), 2942 (aromatic
C-H str), 1693 (C=O str), 1622, 1510 (aromatic, C=C str), 1475, 1363, 1120, 1031. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.69 (s, br, D2O exchangeable, 1H), 8.32 (d, J=8.0 Hz, 1H), 7.79 (d, J=8.0 Hz, 1H),
7.65 (t, J=7.5 Hz, 1H), 7.53 (t, J=8.0 Hz, 1H), 7.45 (t, J=8.0 Hz, 2H), 7.35 (m, 2H), 5.83 (s, 1H), 2.62
(m, 2H), 2.22 (m, 1H), 2.01 (m, 1H), 1.05 (s, 3H), 0.89 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm):
190.7, 160.0, 152.0, 148.6, 138.8, 136.2, 133.3, 132.5, 132.2, 130.5, 127.7, 124.1, 123.9, 123.7, 120.8,
116.8, 108.6, 103.5, 35.2, 30.6, 25.9, 21.0. HRMS-ESI (m/z): [M+Na+.] calcd for C24H20N2O5: 439.1270;
found 439.1216.
10,10-Dimethyl-7-(3-nitrophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4k):
o
Light yellow solid. Yield: 89%. Mp 282-284 C. IR νmax (KBr, cm-1): 3424 (NH str), 3125, 2947
1
(aromatic C-H str), 1657 (C=O str), 1517 (aromatic, C=C str), 1472, 1357, 1187, 1051. H-NMR
(DMSO-d6, 500 MHz) δ (ppm): 9.84 (s, br, D2O exchangeable, 1H), 8.32 (d, J=8.5 Hz, 1H), 8.05 (d,
J=8.5 Hz, 1H), 7.99 (m, 1H), 7.72 (d, J=8.0 Hz, 1H), 7.67 (m, 1H), 7.52 (m, 1H), 7.44 (m, 1H), 7.39 (m,
1H), 5.07 (s, 1H), 2.69 (d, J=4.0 Hz, 2H), 2.28 (d, J=16.0 Hz, 1H), 2.08 (d, J=16.0 Hz, 1H), 1.08 (s, 3H),
13
1.06 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.2, 160.6 (C=O), 152.5, 150.8, 148.1, 147.9,
135.0, 132.7, 129.9, 124.5, 123.5, 122.6, 121.8, 117.3, 113.2, 110.4, 101.3, 99.9, 50.3, 35.4, 32.6, 29.4,
26.8. HRMS-ESI (m/z): [M+Na+.] calcd for C24H20N2O5: 439.1270; found 439.1230.
10,10-Dimethyl-7-(thiophen-2-yl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4l):

1646
HETEROCYCLES, Vol. 85, No. 7, 2012
Light yellow solid. Yield: 90%. Mp 294-296 oC. IR νmax (KBr, cm-1): 3427 (NH str), 2954 (aromatic C-H
str), 1708 (C=O str), 1602 (aromatic, C=C str), 1472, 1361, 1192, 1046. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.84 (s, br, D2O exchangeable, 1H), 8.28 (dd, J=8.0, 1.0 Hz, 1H), 7.64 (d, J=7.5 Hz, 1H), 7.43
(m, 2H), 7.22 (dd, J=5.0, 1.0 Hz, 1H), 6.83 (dd, J=5.0, 3.5 Hz, 1H), 6.78 (d, J=3.0 Hz, 1H), 5.28 (s, 1H),
13
2.65 (m, 2H), 2.30 (d, J=16.0 Hz, 1H), 2.17 (d, J=16.0 Hz, 1H), 1.08 (s, 3H), 1.02 (s, 3H). C NMR
(DMSO-d6, 125 MHz) δ (ppm): 194.9, 160.6 (C=O), 152.38, 150.3, 149.6, 142.5, 132.5, 127.0, 124.5,
124.4, 124.0, 123.3, 117.3, 113.3, 110.7, 101.5, 50.4, 32.5, 29.5, 29.4, 26.9. HRMS-ESI (m/z): [M+Na+.]
calcd for C22H19NSO3: 400.0983; found 400.0913.
10,10-Dimethyl-7-(4-nitrophenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4m):
o
Yellow colour solid. Yield: 90%. Mp 318-320 C. IR νmax (KBr, cm-1): 3419 (NH str), 2957 (aromatic
C-H str), 1689 (C=O str), 1641, 1514 (aromatic, C=C str), 1472, 1352, 1151, 1053. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.80 (s, br, D2O exchangeable, 1H), 8.32 (d, J=8.0 Hz, 1H), 8.09 (d, J=9.0 Hz, 2H),
7.64 (t, J=7.5 Hz, 1H), 7.51 (d, J=9.0 Hz, 2H), 7.45-7.37 (m, 3H), 5.06 (s, 1H), 2.67 (m, 2H), 2.26 (m,
13
1H), 2.10 (m, 1H), 1.07 (s, 3H), 0.92 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.6, 160.1,
153.0, 152.1, 150.2, 145.9, 142.7, 132.2, 129.1, 124.1, 123.2, 123.1, 116.9, 112.8, 109.9, 100.7, 49.9, 35.2,
32.1, 28.9, 26.6. HRMS-ESI (m/z): [M+Na+.] calcd for C24H20N2O5: 439.1270; found 439.1210.
10,10-Dimethyl-7-(2-hydroxyphenyl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione
(4n):
Light yellow solid. Yield: 92%. Mp 308-310 oC. IR νmax (KBr, cm-1): 3427 (NH str), 2954 (aromatic C-H
str), 1665 (C=O str), 1603 (aromatic, C=C str), 1477, 1367, 1199, 1050. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.75 (s, br, D2O exchangeable, 1H), 9.20 (s, br, D2O exchangeable, 1H), 8.32 (d, J=8.0 Hz, 1H),
7.64 (t, J=7.0 Hz, 1H), 7.45 (t, J=8.0 Hz, 1H), 7.38 (d, J=8.0 Hz, 1H), 7.05 (dd, J=7.0, 1.5 Hz, 1H), 6.95
(m, 1H), 6.67 (m, 2H), 5.02 (s, 1H), 2.63 (m, 2H), 2.29 (d, J=16.0 Hz, 1H), 2.09 (d, J=16.0 Hz, 1H), 1.07
(s, 3H), 0.92 (s, 3H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 196.3, 160.8 (C=O), 155.0, 152.3, 151.3,
143.0, 132.2, 132.1, 130.6, 127.7, 124.3, 123.2, 119.4, 117.2, 116.9, 113.4, 110.3, 101.5, 50.3, 32.4, 31.2,
29.5, 26.6. HRMS-ESI (m/z): [M+Na+.] calcd for C24H21NO4: 410.1368; found 410.1314.
10,10-Dimethyl-7-(furan-2-yl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione (4o):
Greay colour solid. Yield: 91%. Mp 308-310 oC. IR νmax (KBr, cm-1): 3431 (NH), 2942 (aromatic C-H str),
1
1711 (C=O str), 1603 (aromatic, C=C str), 1469, 1363, 1150, 1025. H-NMR (DMSO-d6, 500 MHz) δ
(ppm): 9.78 (s, br, D2O exchangeable, 1H), 8.29 (d, J=8.0 Hz, 1H), 7.65 (m, 1H), 7.44-7.37 (m, 3H), 6.26
(dd, J=3.0, 2.0 Hz, 1H), 6.00 (d, J=3.0 Hz, 1H), 5.13 (s, 1H), 2.63 (m, 2H), 2.28 (d, J=8.0 Hz, 1H), 2.15

HETEROCYCLES, Vol. 85, No. 7, 2012
1647
13
(d, J=8.0 Hz, 1 Hz), 1.08 (s, 3H), 0.99 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.5, 160.0,
156.4, 151.9, 150.4, 142.6, 141.3, 132.1, 124.0, 122.8, 116.9, 112.9, 110.4, 107.8, 105.1, 50.0, 32.1, 29.0,
27.9, 26.3. HRMS-ESI (m/z): [M+Na+.] calcd for C22H19NO4: 384.1212; found 384.1180.
10,10-Dimethyl-7-((E)-styryl)-7,10,11,12-tetrahydro-9H-chromeno[4,3-b]quinoline-6,8-dione (4p):
Light yellow solid. Yield: 91%. Mp 202-204 oC. IR νmax (KBr, cm-1): 3431 (NH str), 2956 (aromatic C-H
str), 1681 (C=O str), 1509 (aromatic, C=C str), 1473, 1371, 1196, 1054. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.64 (s, br, D2O exchangeable, 1H), 8.27 (d, J=7.0 Hz, 1H), 7.65 (m, 1H), 7.44 (dd, J=12, 7.5
Hz, 2H), 7.29-7.22 (m, 4H), 7.17 (d, J=7.0 Hz, 1H), 6.22 (m, 2H), 4.60 (d, J=5.5 Hz, 1H), 2.62 (m, 2H),
13
2.26 (m, 2H), 1.08 (s, 3H), 1.07 (s, 3H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.2, 160.8 (C=O),
152.5, 150.6, 143.1, 137.1, 132.3, 131.4, 129.3, 128.9, 127.6, 126.4, 124.3, 123.2, 117.3, 113.5, 109.4,
100.2, 50.5, 32.6, 31.5, 29.3, 27.2. HRMS-ESI (m/z): [M+Na+.] calcd for C26H23NO3: 420.1576; found
420.1521.
7-Phenyl-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5a):
o
Yellow colour solid. Yield: 92%. Mp 324-326 C. IR νmax (KBr, cm-1): 3435 (NH str), 2938 (aromatic
C-H str), 1703 (C=O str), 1634, 1508 (aromatic, C=C str), 1467, 1363, 1174, 1032. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.74 (s, br, D2O exchangeable, 1H), 8.31 (d, J=8.0 Hz, 1H), 7.63 (m, 1H), 7.43 (t, J=
8.0 Hz, 1H), 7.37 (d, J=8.0 Hz, 1H), 7.24-7.18 (m, 4H), 7.09 (t, J=7.0 Hz, 1H), 5.00 (s, 1H), 2.84 (m,
1H), 2.71 (m, 1H), 2.30 (m, 2H), 2.00 (m, 1H), 1.90 (m, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm):
194.9, 160.3, 152.0, 151.6, 145.9, 142.0, 131.9, 128.0, 127.6, 126.1, 123.9, 122.9, 116.8, 113.0, 111.8,
101.7, 36.6, 34.1, 26.3, 20.7. HRMS-ESI (m/z): [M+Na+.] calcd for C22H17NO3: 366.1106; found
366.1086.
7-(Naphthalen-1-yl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5b):
o
White solid. Yield: 90%. Mp 328-330 C. IR νmax (KBr, cm-1): 3433 (NH str), 2950 (aromatic C-H str),
1
1707 (C=O str), 1602 (aromatic, C=C str), 1470, 1359, 1176, 1029. H-NMR (DMSO-d6, 500 MHz) δ
(ppm): 9.84 (s, br, D2O exchangeable, 1H), 8.82 (d, J=9.0 Hz, 1H), 8.38 (d, J=8.0 Hz, 1H), 7.81 (d,
J=8.0 Hz, 1H), 7.69 (d, J=7.0 Hz, 1H), 7.63 (t, J=7.0 Hz, 1H), 7.57 (t, J=8.0 Hz, 1H), 7.47 (dd, J=13.0,
7.5 Hz, 2H), 7.35 (dd, J=4.5, 11.0 Hz, 2H), 5.76 (s, 1H), 2.86 (m, 1H), 2.74 (m, 1H), 2.25 (dd, J=11.0,
5.0 Hz, 1H), 2.16 (m, 1H), 1.98 (m, 1H), 1.85 (m, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.0,
160.3, 151.8, 151.1, 141.7, 132.7, 131.8, 130.7, 127.6, 126.8, 126.5, 125.7, 125.6, 125.3, 123.9, 122.9,
116.8, 113.8, 113.1, 103.5, 36.6, 29.6, 26.5, 20.6. HRMS-ESI (m/z): [M+Na+.] calcd for C26H19NO3:
416.1263; found 416.1210.

1648
HETEROCYCLES, Vol. 85, No. 7, 2012
7-(4-Hydroxyphenyl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5c):
o
Yellow colour solid. Yield: 91%. Mp 338-340 C. IR νmax (KBr, cm-1): 3442 (NH str), 2930 (aromatic
C-H str), 1672 (C=O str), 1630, 1511 (aromatic, C=C str), 1469, 1366, 1178, 1037. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.66 (s, br, D2O exchangeable, 1H), 9.14 (s, br, D2O exchangeable, 1H), 8.28 (d, J=
8.0 Hz, 1H), 7.58 (t, J=8.5 Hz, 1H), 7.40 (d, J=8.0 Hz, 1H), 7.34 (d, J=8.0 Hz, 1H), 7.02 (d, J=8.5 Hz,
2H), 6.59 (d, J=8.5 Hz, 2H), 4.89 (s, 1H), 2.81 (m, 1H), 2.68 (m, 1H), 2.28 (m, 2H), 1.99 (m, 1H), 1.91
(m, 1H). 13C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.9, 160.4, 155.7, 151.9, 151.2, 141.6, 136.6, 131.7,
128.6, 123.8, 122.8, 116.7, 114.7, 113.0, 112.2, 102.2, 36.7, 33.0, 26.3, 20.7. HRMS-ESI (m/z): [M+Na+.]
calcd for C22H17NO4: 382.1055; found 382.1011.
7-(3,4,5-Trimethoxyphenyl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5d):
o
Yellow colour solid. Yield: 89%. Mp 290-292 C. IR νmax (KBr, cm-1): 3406 (NH str), 2934 (aromatic
C-H str), 1669 (C=O str), 1635, 1508 (aromatic, C=C str), 1414, 1366, 1183, 1042. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.78 (s, br, D2O exchangeable, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.62 (t, J=8.0 Hz, 1H),
7.42 (t, J=8.0 Hz, 1H), 7.37 (d, J=8.0 Hz, 1H), 6.51 (s, 2H), 4.99 (s, 1H), 3.67 (s, 6H), 3.57 (s, 3H),
2.89 (m, 1H), 2.72 (m, 1H), 2.32 (m, 2H), 2.04 (m, 1H), 1.94 (m, 1H). 13C NMR (DMSO-d6, 125 MHz) δ
(ppm): 195.0, 160.5, 152.5, 151.9, 151.9, 141.8, 141.2, 131.9, 123.9, 122.9, 116.8, 113.0, 111.2, 104.9,
101.6, 59.8, 55.7, 36.7, 33.8, 26.3, 21.0. HRMS-ESI (m/z): [M+Na+.] calcd for C25H23NO6: 456.1423;
found 456.1395.
7-(3-Nitrophenyl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5e):
o
Yellow colour solid. Yield: 90%. Mp 296-298 C. IR νmax (KBr, cm-1): 3446 (NH str), 2945 (aromatic
C-H str), 1702 (C=O str), 1604, 1517 (aromatic, C=C str), 1470, 1350, 1172, 1025. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.87 (s, br, D2O exchangeable, 1H), 8.34 (d, J=8.0 Hz, 1H), 7.99 (d, J=8.0 Hz, 1H),
7.71 (d, J=8.0 Hz, 1H), 7.65 (t, J=7.5 Hz, 1H), 7.53 (d, J=8.0 Hz, 1H), 7.45 (t, J=8.5 Hz, 1H), 7.41 (d,
J=7.0 Hz, 1H), 7.38 (d, J=8.0 Hz, 1H), 5.11 (s, 1H), 2.87 (m, 1H), 2.74 (m, 1H), 2.31 (m, 2H), 2.03 (m,
13
1H), 1.90 (m, 1H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.0, 160.2, 152.3, 152.1, 147.8, 147.5,
142.5, 134.5, 132.2, 129.6, 124.0, 123.1, 122.2, 121.3, 116.9, 112.8, 111.0, 100.8, 36.5, 34.7, 26.3, 20.6.
HRMS-ESI (m/z): [M+Na+.] calcd for C22H16N2O5: 411.0957; found 411.0901.
7-(Thiophen-2-yl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5f):
Light yellow solid. Yield: 91%. Mp 336-338 oC. IR νmax (KBr, cm-1): 3441 (NH str), 2962 (aromatic C-H
str), 1683 (C=O str), 1532 (aromatic, C=C str), 1463, 1356, 1176, 1023. 1H-NMR (DMSO-d6, 500 MHz)
δ (ppm): 9.90 (s, br, D2O exchangeable, 1H), 8.30 (d, J=8.0 Hz, 1H), 7.64 (d, J=8.0 Hz, 1H), 7.43 (q, J=

HETEROCYCLES, Vol. 85, No. 7, 2012
1649
8.0 Hz, 2H), 7.21 (dd, J=5.0, 1.0 Hz, 1H), 6.83 (m, 1H), 6.77 (m, 1H), 5.30 (s, 1H), 2.82 (m, 1H), 2.70
13
(m, 1H), 2.35 (m, 2H), 2.03 (m, 1H), 1.91 (m, 1H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 195.2,
160.7, 152.3, 152.2, 149.8, 142.3, 132.4, 127.0, 124.4, 123.9, 123.2, 117.2, 113.3, 111.7, 101.5, 37.0, 29.2,
26.7, 21.1. HRMS-ESI (m/z): [M+Na+.] calcd for C20H15NSO3: 372.0670; found 372.0611.
7-(2-Hydroxyphenyl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5g):
o
Yellow colour solid. Yield: 88%. Mp above 360 C. IR νmax (KBr, cm-1): 3452 (NH str), 2934 (aromatic
C-H str), 1683 (C=O str), 1629, 1601 (aromatic, C=C str), 1473, 1369, 1183, 1044. 1H-NMR (DMSO-d6,
500 MHz) δ (ppm): 9.85 (s, br, D2O exchangeable, 1H), 9.27 (s, br, D2O exchangeable, 1H), 8.34 (d, J=
8.0 Hz, 1H), 7.64 (t, J=7.5 Hz, 1H), 7.45 (t, J=7.5 Hz, 1H), 7.38 (d, J=8.0 Hz, 1H), 6.96 (m, 2H), 6.67
13
(m, 2H), 5.04 (s, 1H), 2.78 (m, 1H), 2.69 (m, 1H), 2.33 (m, 2H), 1.99 (m, 1H), 1.90 (m, 1H). C NMR
(DMSO-d6, 125 MHz) δ (ppm): 196.7, 160.4, 154.3, 153.1, 151.9, 142.6, 132.1, 131.9, 129.7, 127.4,
123.9, 122.9, 119.3, 116.8, 116.7, 112.9, 111.2, 101.2, 36.3, 30.1, 26.4, 20.5. HRMS-ESI (m/z): [M+Na+.]
calcd for C22H17NO4: 382.1055; found 382.1007.
7-(Furan-2-yl)-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5h):
o
Gray colour solid. Yield: 90%. Mp 303-305 C. IR νmax (KBr, cm-1): 3440 (NH str), 2951 (aromatic C-H
str), 1673 (C=O str), 1639, 1510 (aromatic, C=C str), 1472, 1365, 1170, 1047. 1H-NMR (DMSO-d6, 500
MHz) δ (ppm): 9.82 (s, br, D2O exchangeable, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.64 (t, J=7.5 Hz, 1H),
7.44-7.37 (m, 2H), 6.25 (dd, J=3.0, 2.0 Hz, 1H), 5.99 (d, J=3.0 Hz, 1H), 5.16 (s, 1H), 2.82 (m, 1H), 2.67
13
(m, 1H), 2.32 (m, 2H), 2.00 (m, 1H), 1.90 (m, 1H). C NMR (DMSO-d6, 125 MHz) δ (ppm): 194.7,
160.1, 156.5, 152.3, 152.0, 142.6, 141.3, 132.0, 124.0, 122.8, 116.9, 112.9, 110.3, 108.9, 105.2, 99.5, 98.7,
36.6, 27.9, 26.4, 20.7. HRMS-ESI (m/z): [M+Na+.] calcd for C20H15NO4: 356.0899; found 356.0821.
(E)-7-Styryl-8,9,10,12-tetrahydro-7H-chromeno[4,3-b]quinoline-6,8-dione (5i):
Light yellow solid. Yield: 91%. Mp 164-166 oC. IR νmax (KBr, cm-1): 3448 (NH), 2946 (aromatic C-H str),
1
1682 (C=O str), 1638, 1508 (aromatic, C=C str), 1473, 1370, 1179, 1035. H-NMR (DMSO-d6, 500
MHz) δ (ppm): 9.70 (s, br, D2O exchangeable, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.65 (d, J=8.0 Hz, 1H), 7.43
(m, 2H), 7.31 (d, J=7.0 Hz, 2H), 7.25 (m, 1H), 7.16 (d, J=7.0 Hz, 1H), 6.18 (t, J=7.0 Hz, 2H), 4.62 (d,
J=5.5 Hz, 1H), 2.80 (m, 1H), 2.71 (m, 1H), 2.37 (m, 2H), 2.00 (m, 2H). 13C NMR (DMSO-d6, 125 MHz)
δ (ppm): 195.0, 160.4, 152.2, 152.1, 142.5, 136.7, 131.9, 130.8, 128.6, 128.4, 127.2, 126.0, 123.9, 122.8,
116.9, 113.1, 109.8, 36.7, 31.0, 26.4, 20.8. HRMS-ESI (m/z): [M+Na+.] calcd for C24H19NO3: 392.1263;
found 392.1213.

1650
HETEROCYCLES, Vol. 85, No. 7, 2012
X-Ray crystallography
The X-ray data collection were performed on a Bruker Kappa Apex four circle-CCD diffractometer using
graphite monochromated MoKα radiation (λ = 0.71070 Å) at 100 K. In the reduction of data Lorentz and
polarization corrections, empirical absorption corrections were applied.27 Crystal structures were solved by
direct methods. Structure solution, refinement and data output were carried out with the SHELXTL
program.28,29 Non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed in
geometrically calculated positions by using a riding model. Images were created in the crystal lattice with
DIAMOND software.30
Table 4. Crystal data and details of structure refinement
S. No.
Chemical formula
Formula weight
Crystal system
3l
C25H19NO4S2
461.55
Triclinic
P-1
4b
C26H26ClNO4S
484.00
Monoclinic
P 21/n
Space group
a (Å)
b (Å)
c (Å)
α (0)
β (0)
10.448(4)
10.511(4)
11.262(4)
88.55(2)
65.14(2)
76.46(2)
1087.3(7)
2
16.187(6)
8.223(3)
17.723(6)
90.00
94.067(18)
90.00
γ (0)
V(Å3)
2353.1(14)
4
Z
Temprature
296(2)
296(2)
DCalc (g/cm3)
µ(Mo Kα) (cm-1)
F(000)
1.410
0.278
480.0
1.366
0.285
1016.0
No. of measured reflections
No. of observed reflections
reflections/restraints/parameters
Goodness-of-fit
3681
2787
3681/2/279
2.379
3885
2538
3885/0/302
2.363
Final R indices[I > 2(I)
R1
0.1255
0.3367
0.1471
0.3668
wR2
ACKNOWLEDGEMENT
We thank Department of Chemistry, IIT Roorkee through MHRD, New Delhi for financial support.
REFERENCES
1. a) J. Zhu and H. Bienaymé, Multicomponent Reactions, Wiley-VCH, Weinheim, 2005; (b) A. Dömling
and I. Ugi, Angew. Chem. Int. Ed., 2000, 39, 3168; (c) G. Guillena, D. J. Ramo, and M. Yus,

HETEROCYCLES, Vol. 85, No. 7, 2012
1651
Tetrahedron: Asymmetry, 2007, 18, 693; (d) D. M. D’souza and T. Muller, J. Chem. Soc. Rev., 2007, 36,
1095; (e) J. Zhu, Eur. J. Org. Chem., 2003, 1133; (f) C. Simon, T. Constantieux, and J. Rodriguez, Eur.
J. Org. Chem., 2004, 4957; (g) V. Nair, C. Rajesh, A. U. Vinod, S. Bindu, A. R. Sreekanth, J. S. Mathen,
and L. Balagopal, Acc. Chem. Res., 2003, 36, 899; (h) B. M. Trost, Angew. Chem., Int. Ed. Engl., 1995,
34, 259.
2. a) D. J. Triggle, Mini Rev. Med. Chem., 2003, 3, 215; (b) A. M. Katz and N. M. Leach, J. Clin.
Pharmacol., 1987, 27, 825; (c) A. Davood, N. Mansouri, A. R. Dehpour, and H. Shafaroudi, Arch.
Pharm. Chem. Life Sci., 2006, 339, 299; (d) A. Shafiee, N. Rastkary, M. Jorjani, and B. Shafaghi, Arch.
Pharm., 2002, 2, 69; (e) J. L Reid, P. A. Meredith, and F. Pasanisi, J. Cardiovasc. Pharmacol., 1985, 7,
S18; (f) R. Shan, C. Velazquez, and E. E. Knaus, J. Med. Chem., 2004, 47, 254; (g) B. Venkata Babu
and N. Ahmed, Heterocycles, 2012, 85, 1155.
3. (a) R. Shan, C. Velazquez, and E. Knaus, J. Med. Chem., 2004, 47, 254; (b) T. Godfaid, R. Miller, and
M. Wibo, Pharmacol. Rev., 1986, 38, 321; (c) P. P. Mager, R. A. Coburn, A. J. Solo, D. J. Trigle, and H.
Rothe, Drug Des. Discovery., 1992, 8, 273; (d) M. Kawase, A. Shah, H. Gaveriya, N. Motohashi, H.
Sakagami, A. Varga, and J. Molnar, Bioorg. Med. Chem., 2002, 10, 1051.
4. (a) L. Fedeli, M. Colozza, E. Boschetti, and I. Sabalich, Cancer, 1989, 6, 1805; (b) M. P. Maguire, K. R.
Sheets, K. McVety, A. P. Spada, and A. Zilberstein, J. Med. Chem., 1994, 37, 2129; (c) R. G. Bretzel, C.
C. Bollen, E. Maester, and K. F. Federlin, Drugs Future, 1992, 17, 465; (d) Y. Sawada, H. Kayakiri, Y.
Abe, T. Mizutani, N. Inamura, M. Asano, C. Hatori, I. Arsmori, T. Oku, and H. Tanaka, J. Med. Chem.,
2004, 47, 2853; (e) K. A. Hahn, A. M. Legendre, and H. M. Schuller, J. Cancer Res. Clin. Oncol., 1997,
123, 34; (f) S. R. Morshed, K. Hashimoto, Y. Murotani, A. Shah, K. Satoh, H. Kikuchi, H. Nishikawa,
J. Maki, H. Sakagami, and M. Kawase, Anticancer Res., 2005, 25, 2033.
5. (a) C. O. Kappe, W. M. F. Fabian, and M. A. Semones, Tetrahedron, 1997, 53, 2803; (b) D. J. Triggle,
Cell Mol. Neurobiol., 2003, 23, 293; (c) M. Schramm, G. Thomas, R. Tower, and G. Franckowiak,
Nature, 1983, 303, 535.
6. K. Gong, H. Wang, J. Luo, and Z. Liu, J. Heterocycl. Chem., 2009, 46, 1145.
7. (a) M. M. Heravi, B. A. Jani, and F. Derikvand, Catal. Commun., 2008, 10, 272; (b) M. M. Heravi, S.
Sadjadi, N. M. Haj, and H. A. Oskooie, Catal. Commun., 2009, 10, 1643.
8. A. Shaabani, S. Samadi, Z. Badri, and A. Rahmati, Catal. Lett., 2005, 104, 39.
9. M. Seifi and H. Sheibani, Catal. Lett., 2008, 126, 275.
10. S. Abdolmohammadi and S. Balalaie, Tetrahedron Lett., 2007, 48, 3299.
11. J. M. Khurana and S. Kumar, Tetrahedron Lett., 2009, 50, 4125.
12. J. M. Khurana, B. Nand, and P. Saluja, Tetrahedron, 2010, 66, 5637.
13. A. R. Karimi and F. Sedaghatpour, Synthesis, 2010, 10, 1731.

1652
HETEROCYCLES, Vol. 85, No. 7, 2012
14. (a) M. M. Heravi, T. Hosseini, F. Derikvand, S. Y. S. Beheshtiha, and F. F. Bamoharram, Synth.
Commun., 2010, 40, 2402; (b) Z. Chen, Q. Zhu, and S. Weike, Tetrahedron Lett., 2011, 52, 2601.
15. M. Nikpassand, M. Mamaghani, and K. Tabatabaeian, Molecules, 2009, 14, 1468.
16. (a) W. Stadlbauer, Monatsh. Chem., 1987, 118, 1297; (b) G. M. Conlin and J. R. Gear, J. Nat. Prod.,
1993, 56, 1402; (c) S. J. Tu, B. Jiang, J. Y. Zhang, R. H. Jia, Y. Zhang, and C. S. Yao, Org. Biomol.
Chem., 2006, 4, 3980; (d) A. T. Khan and D. K. Das, Tetrahedron Lett., 2012, 53, 2345; (e) R. Miri, R.
Motamedi, M. R. Rezaei, O. Firuzi, A. Javidnia, and A. Shafiee, Arch. Pharm. Chem. Life Sci., 2011, 2,
111; (f) S. Paul and A. R. Das, Tetrahedron Lett., 2012, 53, 2206.
17. Q. Zhuang, D. Zhou, S. Tu, C. Li, L. Cao, and Q. Shao, J. Heterocycl. Chem., 2008, 45, 831.
18. (a) I. Kostova, G. Momekov, M. Zaharieva, and M. Karaivanova, Eur. J. Med. Chem., 2005, 40, 542;
(b) I. Manolov, C. Maichle-Moessmer, and N. Danchev, Eur. J. Med. Chem., 2006, 41, 882; (c) N.
Hamdi, M. C. Puerta, and P. Valerga, Eur. J. Med. Chem., 2008, 43, 2541; (d) S. Stanchev, G.
Momekov, F. Jensen, and I. Manolov, Eur. J. Med. Chem., 2008, 43, 694; (e) E. V. Angerer, M.
Kager, and A. Maucher, J. Cancer Res. Clin. Oncol., 1994, 120, S14.
19. (a) M. E. Marshall, K. Kervin, C. Benefield, A. Umerani, S. Albainy-Jenei, Q. Zhao, and M. B.
Khazaeli, J. Cancer Res. Clin. Oncol., 1994, 120, S3; (b) I. Kostova, G. Momekov, M. Zaharieva, and
M. Karaivanova, Eur. J. Med. Chem., 2005, 40, 542; (c) I. Manolov, C. M. Moessmer, and N.
Danchev, Eur. J. Med. Chem., 2006, 41, 882; (d) N. Hamdi, M. C. Puerta, and P. Valerga, Eur. J. Med.
Chem., 2008, 43, 2541; (e) S. Stanchev, G. Momekov, F. Jensen, and I. Manolov, Eur. J. Med. Chem.,
2008, 43, 694; (f) E. V. Angerer, M. Kager, and A. Maucher, J. Cancer Res. Clin. Oncol., 1994, 120,
S14.
20. (a) J. B. Bremner, In Comprehensive Heterocyclic Chemistry II, Vol. 9; ed. by A. R. Katritzky, C. W.
Rees, and E. F. V. Scriven, Elsevier: Oxford, 1996, pp.183-198; (b) M. Kratzel, J. Chem. Soc., Perkin
Trans. 1, 1994, 1541; (c) A. Al-Harrasia, S. Fischera, R. Zimmera, and H.-U. Reissig, Synthesis, 2010,
2, 304; (d) M. Anzini, A. Cappelli, S. Vomero, A. Cagnotto, and M. Skorupska, Med. Chem. Res.,
1993, 3, 44; (e) J. R. Brooks, C. Berman, M. Hichens, R. L. Primka, G. F. Reynolds, and G. H.
Rasmusson, Proc. Soc. Exp. Biol. Med., 1982, 169, 67; (f) A. Rampa, A. Bisi, F. Belluti, S. Gobbi, P.
Valenti, V. Andrisano, V. Cavrini, A. Cavalli, and M. Recanatini, Bioorg. Med. Chem., 2000, 8, 497;
(g) L. W. Deady, A. J. Kaye, G. J. Finlay, B. C. Baguley, and W. A. Denny, J. Med. Chem., 1997, 40,
2040; (h) L. W. Deady, J. Desneves, A. J. Kaye, M. Thompson, G. J. Finlay, B. C. Baguley, and W. A.
Denny, Bioorg. Med. Chem., 1999, 7, 2801.
21. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, V. G.
Zakrzewski, J. A. Montgomery, R. E. Stratmann, J. C. Burant, S. Dapprich, J. M. Millam, A. D. Daniels,
K. N. Kudin, M. C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C.

HETEROCYCLES, Vol. 85, No. 7, 2012
1653
Pomelli, C. Adamo, S. Clifford, J. Ochterski, G. A. Petersson, P. Y. Ayala, Q. Cui, K. Morokuma, D. K.
Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. Cioslowski, J. V. Ortiz, A. G. Baboul, B. B.
Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R. L. Martin, D. J. Fox, T. A.
Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W.
Chen, M. W. Wong, J. L. Andres, C. Gonzalez, M. Head-Gordon, E. S. Replogle, and J. A. Pople,
GAUSSIAN 98, revision A.9; Gaussian Inc.: Pittsburgh, PA, 1998.
22. A. D. Becke, J. Chem. Phys., 1993, 98, 1372.
23. P. J. Stephens, F. J. Devlin, C. F. Chabalowski, and M. J. Frisch, J. Phys. Chem., 1994, 98, 11623.
24. C. T. Lee, W. T. Yang, and R. G. Parr, Phys. Rev. B, 1988, 37, 785.
25. A. Pavlov and P. M. Mitrasinovic, Current Organic Chemistry, 2010, 14, 129.
26. P. M. Mitrasinovic, Bioconjugate Chemistry, 2005, 16, 588.
27. G. M. Sheldrick, SADABS, Program for Scaling and Correction of Area Detector Data, University of
Göttingen, Germany, 1996.
28. G. M. Sheldrick, Acta Crystallographica Section A, 1990, 46, 467.
29. G. M. Sheldrick, SHELXTL-NT, version 6.12, Reference Manual, University of Göttingen, Germany,
2000.
30. K. Brandenburg, Diamond, version 2.1d; Crystal Impact GbR, Bonn, Germany, 2000.